[S17-02] Screening for serological group B streptococci within the framework of the medical check-ups according to the maternity Guidelines

Last updated 05.02.2019

Project no.:
S17-02

Commission:
Commission awarded on 21.12.2017 by the Federal Joint Committee (G-BA).

Report type:
Report

Status:
Commission completed

Department/Division:
Non-Drug Interventions

Application field:
Prevention and screening

05.02.2019

Informative studies are lacking for the comparison with the currently used risk-based strategy.

Press release

Extract of the final report: Screening for serological group B streptococci within the framework of the medical check-ups according to the maternity Guidelines

EN, PDF, 68 kB, PDF

published on Feb 5, 2019
Final report: Screening for serological group B streptococci within the framework of the medical check-ups according to the maternity Guidelines

DE, PDF, 463 kB, PDF

published on Feb 5, 2019
Documentation of comments on the preliminary report: Screening for serological group B streptococci within the framework of the medical check-ups according to the maternity Guidelines

DE, PDF, 2 MB, PDF

published on Feb 5, 2019
Preliminary report: Screening for serological group B streptococci within the framework of the medical check-ups according to the maternity Guidelines

DE, PDF, 473 kB, PDF

published on Jul 27, 2018
Documentation of comments on the report plan: Screening for serological group B streptococci within the framework of the medical check-ups according to the maternity Guidelines

DE, PDF, 53 kB, PDF

published on Jul 27, 2018
Report plan: Screening for serological group B streptococci within the framework of the medical check-ups according to the maternity Guidelines

DE, PDF, 198 kB, PDF

published on Mar 6, 2018

Contact

Press contact

+49 221 356850

presse@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.